US Market for Cardiac Surgery and Heart Valve Devices 2018 Market Report; Launched via MarketResearchReports.com

Cardiac surgery involves the heart and the great vessels connected to the heart. It is often performed to treat ischemic heart disease, congenital heart disease, valvular heart disease as well as heart transplantation. The first cardiac surgeries were performed in the 19th century on the pericardium, the sac that surrounds the heart.

The first surgery on the heart itself was performed in 1895 in Oslo, Norway. Surgeon Axel Cappelen ligated the bleeding coronary artery of a 24-year-old patient who had been stabbed under his left arm. The patient survived for over two days but later passed away due to infection from the procedure. Approximately one year afterwards, a successful operation was performed in Germany on another patient with a stabbing injury.

There are many risks associated with performing cardiac surgery. Patients often suffer from neurological damage and strokes after procedures. Neurological damage is more common when an ONCAB procedure is performed; many patients suffer from post-perfusion syndrome, which is a combination of neurological conditions that can affect patients after surgery. These symptoms can be temporary or permanent.

The U.S. market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVR) devices, transcatheter heart valve replacement (THVR) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), transmyocardial revascularization (TMR) devices, ventricular assist devices (VADs), intra-aortic balloon pumps, temporary artificial heart replacement devices, extracorporeal membrane oxygenation (ECMO), remote hemodynamic monitoring, patent foramen ovale (PFO), atrial septal defect (ASD) devices, ventricular septal defect (VSD) devices and left atrial appendage (LAA) devices.

Several new and innovative devices within this market are expected to emerge over the forecast period, particularly in the heart valve and cardiac assist segments, and as a result, growth in the overall market is expected to accelerate.

Spanning over 366 pages “US Market for Cardiac Surgery and Heart Valve Devices 2018 - MedView” report covers Executive Summary, U.S. Cardiac Surgery And Heart Valve Device Market Overview, Competitive Analysis, Market Trends, Market Developments, Research Methodology, Disease Overview, U.S. Cardiac Surgery And Heart Valve Device Market Overview, Appendix. This report Covered Companies - Edwards Lifesciences, St. Jude Medical, Medtronic, Maquet, Abiomed, HeartWare Inc., Sorin Group, Terumo, Abbott Laboratories, Teleflex Medical, Cardiac Assist, AtriCure, W.L. Gore, SynCardia, Boston Scientific, Cryolife, Others include: Berlin Heart, Cardica, Chase Medical, Genesee Biomedical, Karl Storz, LifeNet Health, Microline Surgical, Novadaq, On-X, Saphena Medical, SentreHeart, Vitalitec, etc.

Please visit this link for more details: http://mrr.cm/UGT

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare